Is Bioventus Inc. (BVS) a Buy, Sell, or Hold?
NASDAQ : BVS
Bioventus Inc. — Analyst Ratings
$13.17 USD
-$0.01 (-0.08%)
- Volume
- 762.38K
- Average Volume
- 681.5K
- Market Capitalization
- $892.24M
- P/E Ratio
- 31.11
- Dividend Yield
- 0.00%
- Price Target
- $14.00
- Year High
- $13.55
- Year Low
- $5.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.69
Analyst Consensus Summary
Consensus Rating
Neutral
6 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-5.9%
vs Current Price
Price Target
$14.00
Average TargetPrice Target Range
Lowest Target
$13.00
1.3% UPSIDE
Average Target
$14.00
Median Estimate
Highest Target
$15.00
-12.2% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 6
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 4 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | Caitlin Cronin | $15 | $8.6 | 2026-06-16 06:37 AM | 74.4% |
| Craig-Hallum | Chase Knickerbocker | $15 | $6.2 | 2025-05-07 09:16 AM | 141.9% |
| Canaccord Genuity | Caitlin Cronin | $12 | $11.79 | 2024-10-01 09:38 AM | 1.8% |
| Craig-Hallum | Chase Knickerbocker | $12 | $8.25 | 2024-08-07 05:05 AM | 45.5% |
| Canaccord Genuity | William Plovanic | $8 | $5.12 | 2024-05-07 09:38 AM | 56.2% |
| Craig-Hallum | Alex Nowak | $9 | $5.29 | 2024-03-13 04:42 AM | 70.1% |